| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Eingereichte Version (1MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-365903
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.36590
Zusammenfassung
Background: Hepatocellular carcinoma (HCC) is the 3rd leading cause of cancer-related death worldwide. The majority of HCCs are diagnosed in a stage that is not eligible for curative resection. For intermediate stage HCC, transarterial chemoembolization (TACE) is the recommended treatment. We evaluated the safety and efficacy of DSM (degradable starch microspheres) as embolic agent in ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik